TriSalus Life Sciences (TLSI) Consolidated Net Income (2022 - 2025)
Historic Consolidated Net Income for TriSalus Life Sciences (TLSI) over the last 4 years, with Q3 2025 value amounting to -$10.8 million.
- TriSalus Life Sciences' Consolidated Net Income fell 35064.61% to -$10.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$39.6 million, marking a year-over-year increase of 2877.86%. This contributed to the annual value of -$30.0 million for FY2024, which is 4938.77% up from last year.
- TriSalus Life Sciences' Consolidated Net Income amounted to -$10.8 million in Q3 2025, which was down 35064.61% from -$8.3 million recorded in Q2 2025.
- In the past 5 years, TriSalus Life Sciences' Consolidated Net Income ranged from a high of $2.8 million in Q1 2022 and a low of -$35.6 million during Q4 2023
- In the last 4 years, TriSalus Life Sciences' Consolidated Net Income had a median value of -$8.3 million in 2025 and averaged -$9.6 million.
- Within the past 5 years, the most significant YoY rise in TriSalus Life Sciences' Consolidated Net Income was 8239.22% (2023), while the steepest drop was 68560.77% (2023).
- Quarter analysis of 4 years shows TriSalus Life Sciences' Consolidated Net Income stood at -$22.5 million in 2022, then plummeted by 58.1% to -$35.6 million in 2023, then soared by 71.64% to -$10.1 million in 2024, then fell by 6.95% to -$10.8 million in 2025.
- Its Consolidated Net Income was -$10.8 million in Q3 2025, compared to -$8.3 million in Q2 2025 and -$10.4 million in Q1 2025.